Diagnosis and management of neuropathic pain: Review of literature and recommendations of the Polish Association for the study of pain and the Polish Neurological Society – part two

Neurologia i Neurochirurgia Polska

Volumn 48, Issue 6, 2014, Pages 423-435

  Szczudlik, Andrzej ^a   Dobrogowski, Jan ^a   Wordliczek, Jerzy ^a   Stępień, Adam ^b   Krajnik, Małgorzata ^c   Leppert, Wojciech ^d   Woroń, Jarosław ^a   Przeklasa Muszyńska, Anna ^a   Kocot Kępska, Magdalena ^a   Zajączkowska, Renata ^a   Janecki, Marcin ^e   Adamczyk, Anna ^c   Malec Milewska, Małgorzata ^f  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b MILITARY INSTITUTE OF MEDICINE   (Poland)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

^f MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Complex regional pain syndrome; Neuropathic pain; Painful diabetic polyneuropathy; Post herpetic neuralgia; Trigeminal neuralgia

Indexed keywords

ACETYLCYSTEINE; ACICLOVIR; ALDOSE REDUCTASE INHIBITOR; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM CHANNEL; CAPSAICIN; CLONAZEPAM; DIAZEPAM; GABAPENTIN; GLUCOSE; LAMOTRIGINE; LIDOCAINE; MEASLES VACCINE; MEXILETINE; NERIDRONIC ACID; NIFEDIPINE; NITRENDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PAMIDRONIC ACID; PARACETAMOL; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TRAMADOL; UNINDEXED DRUG;

COMPLEX REGIONAL PAIN SYNDROME; DIABETIC NEUROPATHY; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS (TOPIC); METABOLIC REGULATION; NEUROPATHIC PAIN; POSTHERPETIC NEURALGIA; POSTOPERATIVE PAIN; POSTTRAUMATIC PAIN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); TRANSCUTANEOUS NERVE STIMULATION; TRIGEMINUS NEURALGIA; ANALGESIA; NEURALGIA; NEUROLOGY; PATIENT CARE; POLAND; PRACTICE GUIDELINE; STANDARDS;

HUMANS; NEURALGIA; NEUROLOGY; PAIN MANAGEMENT; PATIENT CARE TEAM; POLAND; PRACTICE GUIDELINES AS TOPIC;

EID: 84925284879     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.1016/j.pjnns.2014.11.002     Document Type: Review

References (116)

1. Abraham R, Marouani N, Weinbroum A. Dextromethorphan mitigates phantom pain in cancer amputees. Ann Surg Oncol 2003;10:268–74.
2. Abuaisha BB, Costanzi JB, Boulton AJ. Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract 1998;39:115–21.
3. Alviar MJ, Hale T, Dungca M. Pharmacologic interventions for treating phantom limb pain. Cochrane Database Syst Rev 2011;12. CD006380.
4. American Society of Anesthesiologists Task Force on Chronic Pain Management, American Society of Regional Anesthesia and Pain Medicine. Practice guidelines for chronic pain management: an updated report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain Medicine. Anesthesiology 2010;112:810–33.
5. Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010;17:1113–23.
6. Attal N, Cruccu G, Haanpää M, Hansson P, Jensen TS, Nurmikko T, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13: 1153–69.
7. Bandyk DF, Johnson BL, Kirkpatrick AF, Novotney ML, Back MR, Schmacht DC. Surgical sympathectomy for reflex sympathetic dystrophy syndromes. J Vasc Surg 2002;35:269–77.
8. Bansal D, Bhansali A, Hota D, Chakrabarti A, Dutta P. Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial. Diabet Med 2009;26:1019–26.
9. Barbano RL, Herrman DN, Hart-Gouleau S. Effectiveness, tolerability and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol 2004;61:914–8.
10. Batoz H, Verdonck O, Pellerin C, Roux G, Maurette P. The analgesic properties of scalp infiltrations with ropivacaine after intracranial tumor resection. Anesth Analg 2009;109:240–4.
11. Beiske AG, Loge JH, Rønningen A, Svensson E. Pain in Parkinsons disease: prevalence and characteristics. Pain 2009;141:173–7.
12. Benzon HT, Chekka K, Darnule A, Chung B, Wille O, Malik K. Evidence-based case report: the prevention and management of postherpetic neuralgia with emphasis on interventional procedures. Reg Anesth Pain Med 2009;34:514–21.
13. Binder A, Baron R. Complex regional pain syndromes. In: McMahon SB, Koltzenburg M, Tracey I, Turk D, editors. Wall and Melzack's Texbook of Pain. Philadelphia: Saunders-Elsevier; 2013. p. 961–77.
14. Blaes F, Tschernatsch M. Paraneoplastic neurological disorders. Exp Rev Neurother 2010;10:1559–68.
15. Bone M, Critchley P, Buggy DJ. Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study. Region Anesth Pain Med 2002;27:481–6.
16. Borsook D. Neurological diseases and pain. Brain 2012;135:320–44.
17. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28:956–62.
18. Brefel-Courbon C, Payoux P, Thalamas C, Ory F, Quelven I, Chollet F, et al. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Dis 2005;20:1557–63.
19. Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011;76:1758–65.
20. Brown S, Simpson DM, Moyle G, Brew BJ, Schifitto G, Larbalestier N, et al. NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials. AIDS Res Ther 2013;10:15.
21. Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 2012;13:e58–68.
22. Cepeda MS, Lau J, Carr DB. Defining the therapeutic role of local anesthetic sympathetic blockade in complex regional pain syndrome: a narrative and systematic review. Clin J Pain 2002;18:216–33.
23. Chaparro LE, Wiffen PJ, Moore RA, Gilron I. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database Syst Rev 2012;11(7). CD008943.
24. Chetty S, Baalbergen E, Bhigjee AI, Kamerman P, Ouma J, Raath R, et al. Clinical practice guidelines for management of neuropathic pain: expert panel recommendations for South Africa. S Afr Med J 2012;102:312–25.
25. Childs EA, Lyles RH, Selnes OA, Chen B, Miller EN, Cohen BA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 1999;52:607–13.
26. Colding A. The effect of regional sympathetic blocks in the treatment of herpes zoster: a survey of 300 cases. Acta Anaesthesiol Scand 1969;13:133–41.
27. Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 2008;15:1013–28.
28. Cruccu G, Truini A. Refractory trigeminal neuralgia: non- surgical treatment options. CNS Drugs 2013;27:91–6.
29. Czech A, Taton J, Bernas M. Kompendium Diabetologii. Gdansk: Via Medica; 2000.
30. De Jong JR, Vlaeyen JW, Onghena P, Cuypers C, den Hollander M, Ruijgrok J. Reduction of pain-related fear in complex regional pain syndrome type I: the application of graded exposure in vivo. Pain 2005;116:264–75.
31. Detlef C, Constanze M, Wilfried V, Matthias H, Neundorfer B. Assessment of diabetic neuropathy: definition of norm and discrimination of abnormal nerve function. Muscle Nerve 1993;16:757–68.
32. Dobrogowski J, Wordliczek J. Terapia bólu neuropatycznego. Nowa Medycyna 2002;5:10–6.
33. Dorfman D, George MC, Schnur J, Simpson DM, Davidson G, Montgomery G. Hypnosis for treatment of HIV neuropathic pain: a preliminary report. Pain Med 2013;14:1048–56.
34. Dropcho EJ. Neurotoxicity of radiation therapy. Neurol Clin 2010;28:217–34.
35. Durand JP, Deplanque G, Montheil V, Gornet JM, Scotte F, Mir O, et al. Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Ann Oncol 2012;23:200–5.
36. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003;60:1524–34.
37. Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007;44:1–26.
38. Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpaa ML, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010;85 (Suppl. 3):S3–14.
39. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132:237–51.
40. Dworkin RH, O'Connor AB, Kent J, Mackey SC, Raja SN, Stacey BR, et al. Interventional management of neuropathic pain: NeuPSIG recommendations. Pain 2013;154:2249–61.
41. Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain 1996;67:241–51.
42. Eichenberger U, Neff F, Sveticic G, Bjorgo S, Petersen-Felix S, Arendt-Nielsen L, et al. Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds. Anesth Analg 2008;106:1265–73.
43. Estanislao L, Carter K, McArthur J, Olney R, Simpson D. Lidoderm-HIV Neuropathy Group. A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy. J Acquir Immune Defic Syndr 2004;37:1584–6.
44. Fallon MT. Neuropathic pain in cancer. Br J Anaesth 2013;111:105–11.
45. Farquhar-Smith P. Chemotherapy-induced neuropathic pain. Curr Opin Support Palliat Care 2011;5:1–7.
46. Fassoulaki A, Patris K, Sarantopoulos C, Hogan Q. The analgesic effect of gabapentin and mexiletine after breast surgery for cancer. Anesth Analg 2002;95:985–91.
47. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomized, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regiments. Pain 2005;115:254–63.
48. Griffo Y, Obbens EA. Neurological complications. In: Walsh D, editor. Palliative and medicine. Philadelphia: Saunders-Elsevier; 2009. p. 1237–40.
49. Grigoras A, Lee P, Sattar F, Shorten G. Perioperative intravenous lidocaine decreases the incidence of persistent pain after breast surgery. Clin J Pain 2012;28:567–72.
50. Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 2008;71:1183–90.
51. Gwak YS, Hulsebosch CE. GABA and central neuropathic pain following spinal cord injury. Neuropharmacology 2011;60:799–808.
52. Hahn K, Arendt G, Braun JS, von Giesen HJ, Husstedt IW, Maschke M, et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol 2004;251:1260–6.
53. Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med 2007;8:326–31.
54. Harden RN, Oaklander AL, Burton AW, Perez RS, Richardson K, Swan M, et al. Complex regional pain syndrome: practical diagnostic and treatment guidelines, 4th edition. Pain Med 2013;14:180–229.
55. Hollingshead J, Dühmke RM, Cornblath DR. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2006;19(3): CD003726.
56. Hsu ES. Practical management of complex regional pain syndrome. Am J Ther 2009;16:147–54.
57. Hsu E, Cohen SP. Post-amputation pain: epidemiology, mechanisms, and treatment. J Pain Res 2013;6:121–36.
58. Huse E, Larbig W, Flor H, Birbaumer N. The effect of opioids on phantom limb pain and cortical reorganization. Pain 2001;90:47–55.
59. Jaggi AS, Singh N. Mechanisms in cancerchemotherapeutic drugs-induced peripheral neuropathy. Toxicology 2012;291:1–9.
60. Janjan N, Lin E, Mc Cutcheon I, Perkins G, Das P, Krishnan S, et al. Vertebral metastases and spinal cord compression. In: Walsh D, editor. Palliative medicine. Philadelphia: Saunders-Elsevier; 2009. p. 1247–60.
61. Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004;62:1545–51.
62. Kairaluoma PM, Bachmann MS, Rosenberg PH, Pere PJ. Preincisional paravertebral block reduces the prevalence of chronic pain after breast surgery. Anesth Analg 2006;103:703–18.
63. Kaur H, Hota D, Bhansali A, Dutta P, Bansal D, Chakrabarti A. A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy. A randomized, double-blind, cross-over clinical trial. Diabetes Care 2011;34:818–22.
64. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet 2006;367:1618–25.
65. Kemler MA, Barendse GA, van Kleef M, de Vet HC, Rijks CP, Furnee CA. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med 2000;343:618–24.
66. Klit H, Finnerup NB, Jensen TS. Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol 2009;8:857–68.
67. Knotkova H, Cruciani RA, Tronnier VM, Rasche D. Current and future options for the management of phantom-limb pain. J Pain Res 2012;5:39–49.
68. Koopman JS, de Vries LM, Dieleman JP, Huygen FJ, Stricker BH, Sturkenboom MC. A nationwide study of tree invasive treatments for trigeminal neuralgia. Pain 2011;152:507–13.
69. Koopman JS, Dieleman JP, Huygen FJ, de Mos M, Martin CG, Strukenboom MC. Incidence of facial pain in the general population. Pain 2009;147:122–7.
70. Lavand'homme P, De Kock M, Waterloos H. Intraoperative epidural analgesia combined with ketamine provides effective preventive analgesia in patients undergoing major digestive surgery. Anesthesiology 2005;103:813–20.
71. Lee BH, Scharff L, Sethna NF, McCarthy CF, Scott- Sutherland J, Shea AM. Physical therapy and cognitivebehavioral treatment for complex regional pain syndromes. J Pediatr 2002;141:135–40.
72. Malec-Milewska M, Woron J, editors. Kompendium leczenia bólu. Warszawa: Medical Education; 2012.
73. Manicourt DH, Brasseur JP, Boutsen Y, Depreseux G, Devogelaer JP. Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity. Arthritis Rheum 2004;50: 3690–7.
74. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2012;12:CD008242.
75. Moseley CL. Is successful rehabilitation of complex regional pain syndrome due to sustained attention to the affected limb. A randomised clinical trial. Pain 2005;114:54–61.
76. Makharita MY, Amr YM, El-Bayoumy Y. Effect of early stellate ganglion blockade for facial pain from acute herpes zoster and incidence of postherpetic neuralgia. Pain Phys 2012;15:467–74.
77. Mishra S, Bhatnagar S, Goyal GN, Rana SPS, Upadhya SP. A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study. Am J Hosp Palliat Med 2012;29:177–82.
78. Nguyen JP, Lefaucheur JP, Raoul S, Roualdes V, Pereon Y, Keravel Y. Motor cortex stimulation for the treatment of neuropathic pain. In: Krames ES, Peckham PH, Rezai AR, editors. Neuromodulation. 1st ed. Amsterdam: Elsevier Science; 2009. p. 515–26.
79. Nikolajsen L, Hansen C, Nielsen J, Keller J, Arendt-Nielsen L, Jensen T. The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain 1996;67:69–77.
80. Nikolajsen L. Phantom limb pain. In: Stannard C, Kalso E, Ballantyne J, editors. Evidence-based chronic pain management. Chichester: Wiley-Blackwell; 2010. p. 237–47.
81. Oerlemans HM, Oostendorp RA, de Boo T, Goris RJ. Evaluation of three methods to rate impairment in patients with complex regional pain syndrome I of one upper extremity. Clin Rehabil 2000;14:331–9.
82. Osterberg A, Boivie J, Thuomas KA. Central pain in multiple sclerosis: prevalence and clinical characteristics. Eur J Pain 2005;9:531–42.
83. Oxman MN, Levin MJ, Johnson GR, Schmander KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271–84.
84. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:89–94.
85. Peltier A, Goutman SA, Callaghan BC. Painful diabetic neuropathy. BMJ 2014;348:g1799. http://dx.doi.org/10.1136/bmj.g1799.
86. Perez RS, Zollinger PE, Dijksra PU, Thomassen-Hilgersome IL, Zuurmond WW, Rosenbrandt KCJ, et al. Evidence based guidelines for complex regional pain syndrome type I. BMC Neurol 2010;10:20. http://dx.doi.org/10.1186/1471-2377-10-20.
87. Perkins F, Ballantyne J. Postsurgical pain syndromes. In: Stannard CF, Kalso E, Ballantyne J, editors. Evidence-based chronic pain management. Chichester: Wiley-Blackwell; 2010. p. 194–203.
88. Phillips K, Clauw DJ. Central pain mechanisms in chronic pain states – maybe it is all in their head. Best Pract Res Clin Rheumatol 2011;25:141–54.
89. Pollack IF, Jannetta PJ, Bissonette DJ. Bilateral trigeminal neuralgia: a 14-year experience with microvascular decompression. J Neurosurg 1988;68:559.
90. Pollmann W, Feneberg W. Current management of pain associated with multiple sclerosis. CNS Drugs 2008;22: 291–324.
91. Raptis E, Vadalouca A, Stavropoulou E, Argyra E, Melemeni A, Siafaka I. Pregabalin vs opioids for the treatment of neuropathic cancer pain: a prospective, head-to-head, randomized, open-label study. Pain Pract 2014;14:32–42.
92. Richter RW, Portenoy R, Sharma M. Relief of painful diabetic neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005;6:253–60.
93. Robinson LR, Czerniecki JM, Ehde DM. Trial of amitriptyline for relief of pain in amputees: results of a randomized controlled study. Arch Phys Med Rehabil 2004;85:1–6.
94. Rosenstock J, Tuchman M, La Moreau L. Pregabalin for the treatment of painful diabetic neuropathy: a randomized, controlled trial. Pain 2004;110:628–34.
95. Sentürk M, Ozcan PE, Talu GK, Kiyan E, Camci E, Ozyalçin S, et al. The effects of three different analgesia techniques on long-term postthoracotomy pain. Anesth Analg 2002;94:11–5.
96. Simpson DM, McArthur JC, Olney R, Clifford D, So Y, Ross D, et al. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology 2003;60:1508–14.
97. Simpson DM, Schifitto G, Clifford DB, Murphy TK, Durso-De Cruz E, Glue P, et al. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology 2010;74:413–20.
98. Smith D, Ehde D, Hanley M, Campbell K, Jensen M, Hoffman A, et al. Efficacy of gabapentin in treating chronic phantom limb and residual limb pain. J Rehabil Res Dev 2005;42:645–54.
99. Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 2013;309:1359–67.
100. Snedecor SJ, Sudharshan L, Cappelleri JC, Sadosky A, Desai P, Jalundhwala Y, et al. Systematic review and metaanalysis of pharmacological therapies for pain associated with posttherpeutic neuralgia and less common neuropathic conditions. Int J Clin Pract 2014;68:900–18.
101. Subcommittee on Taxonomy IASP. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Pain 1986;(Suppl. 3):S218.
102. Sunder RA, Toshniwal G, Dureja G. Ketamine as an adjuvant in sympathetic blocks for management of central sensitization following peripheral nerve injury. J Brachial Plex Peripher Nerve Inj 2008;25(3):22.
103. Tesfaye S, Vileikyte L, Rayman G, Sindrup SH, Perkins BA, Baconja M, et al. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev 2011;27:629–38.
104. The Diabetes Control, Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in the insulin dependent mellitus. N Eng J Med 1993;329:977–86.
105. Thyregood HG, Rowbotham MC, Peters M, Possehn J, Berro M, Petersen KL. Natural history of pain following herpes zoster. Pain 2007;128:148–56.
106. Trang T, Beggs S, Salter MW. Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain. Neuron Glia Biol 2011;7:99–108.
107. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain: redefinition and a grading system for clinical research purposes. Neurology 2008;70:1630–5.
108. Vadivelu N, Schreck M, Lopez J, Kodumudi G, Narayan D. Pain after mastectomy and breast reconstruction. Am Surg 2008;74:285–96.
109. Verma A. Epidemiology and clinical features of HIV-1 associated neuropathies. J Peripher Nerv Syst 2001;6:8–13.
110. Wilder-Smith CH, Hill LT, Laurent S. Postamputation pain and sensory changes in treatment-naive patients: characteristics and responses to treatment with tramadol, amitriptyline, and placebo. Anesthesiology 2005;103: 619–28.
111. Winnie AP, Hartwell PW. Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of post-herpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth 1993;18:277–82.
112. Wu CL, Agarwal S, Tella PK, Klick B, Clark MR, Haythornthwaite JA, et al. Morphine versus mexiletine for treatment of postamputation pain: a randomized, placebo controlled, crossover trial. Anesthesiology 2008;109:289–96.
113. Wu CL, Tella P, Staats P, Vaslav R, Kazim D, Wesselmann U, et al. Analgesic effects of intravenous lidocaine and morphine on postamputation pain. Anesthesiology 2002;96:841–8.
114. Zakrzewska JM. Diagnosis and differential diagnosis of trigeminal neuralgia. Clin J Pain 2002;18:14–21.
115. Zollinger PE, Tuinebreijer WE, Breederveld RS. Can vitamin C prevent complex regional pain syndrome in patients with wrist fractures? A randomized, controlled, multicenter dose–response study. J Bone Joint Surg Am 2007;89:1424–31.
116. Zychowska M, Rojewska M, Przewlocka B, Mika J. Mechanisms and pharmacology of diabetic neuropathy – experimental and clinical studies. Pharmacol Rep 2013;65:1601–10.